FDA Oncology Announcements

Anti-PD-L1 × Sarcoma × Clear all

1 Announcement

FDA grants approval to atezolizumab for alveolar soft part sarcoma

Drug: Tecentriq (atezolizumab) · Anti-PD-L1 antibody
Condition: Sarcoma